HomeCompareBAX vs RF

BAX vs RF: Dividend Comparison 2026

BAX yields 2.28% · RF yields 4.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RF wins by $1.19M in total portfolio value
10 years
BAX
BAX
● Live price
2.28%
Share price
$15.80
Annual div
$0.36
5Y div CAGR
-27%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.6K
Annual income
$10.26
Full BAX calculator →
RF
RF
● Live price
4.14%
Share price
$25.24
Annual div
$1.05
5Y div CAGR
57.5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.21M
Annual income
$806,474.51
Full RF calculator →

Portfolio growth — BAX vs RF

📍 RF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBAXRF
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BAX + RF cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BAX pays
RF pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BAX
Annual income on $10K today (after 15% tax)
$193.67/yr
After 10yr DRIP, annual income (after tax)
$8.72/yr
RF
Annual income on $10K today (after 15% tax)
$351.92/yr
After 10yr DRIP, annual income (after tax)
$685,503.33/yr
At 15% tax rate, RF beats the other by $685,494.61/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BAX + RF for your $10,000?

BAX: 50%RF: 50%
100% RF50/50100% BAX
Portfolio after 10yr
$617.5K
Annual income
$403,242.38/yr
Blended yield
65.30%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on RF right now

BAX
Analyst Ratings
15
Buy
20
Hold
1
Sell
Consensus: Hold
Price Target
$19.75
+25.0% upside vs current
Range: $15.00 — $25.00
Altman Z
2.1
Piotroski
5/9
RF
Analyst Ratings
22
Buy
26
Hold
4
Sell
Consensus: Hold
Price Target
$29.89
+18.4% upside vs current
Range: $27.00 — $32.00
Altman Z
-0.4
Piotroski
9/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BAX buys
0
RF buys
0
No recent congressional trades found for BAX or RF in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBAXRF
Forward yield2.28%4.14%
Annual dividend / share$0.36$1.05
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-27%57.5%
Portfolio after 10y$20.6K$1.21M
Annual income after 10y$10.26$806,474.51
Total dividends collected$602.00$1.15M
Payment frequencyquarterlyquarterly
SectorHealthcareFinancials
Analyst consensusHoldHold
Analyst price target$19.75$29.89

Year-by-year: BAX vs RF ($10,000, DRIP)

YearBAX PortfolioBAX Income/yrRF PortfolioRF Income/yrGap
1← crossover$10,866$166.33$11,352$652.09$486.00RF
2$11,750$123.31$13,236$1,089.63$1.5KRF
3$12,664$90.97$16,033$1,870.12$3.4KRF
4$13,617$66.89$20,490$3,334.37$6.9KRF
5$14,619$49.07$28,196$6,272.35$13.6KRF
6$15,679$35.94$42,875$12,705.28$27.2KRF
7$16,802$26.30$74,314$28,437.81$57.5KRF
8$17,998$19.23$152,070$72,553.49$134.1KRF
9$19,272$14.05$381,252$218,537.12$362.0KRF
10$20,631$10.26$1,214,414$806,474.51$1.19MRF

BAX vs RF: Complete Analysis 2026

BAXHealthcare

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit. It also provides connected care solutions, including devices, software, communications, and integration technologies; integrated patient monitoring and diagnostic technologies to help diagnose, treat, and manage a various illness and diseases, including respiratory therapy, cardiology, vision screening, and physical assessment; surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories. In addition, the company offers contracted services to various pharmaceutical and biopharmaceutical companies. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Full BAX Calculator →

RFFinancials

Regions Financial Corporation, a financial holding company, provides banking and bank-related services to individual and corporate customers. It operates through three segments: Corporate Bank, Consumer Bank, and Wealth Management. The Corporate Bank segment offers commercial banking services, such as commercial and industrial, commercial real estate, and investor real estate lending; equipment lease financing; deposit products; and securities underwriting and placement, loan syndication and placement, foreign exchange, derivatives, merger and acquisition, and other advisory services. It serves corporate, middle market, and commercial real estate developers and investors. The Consumer Bank segment provides consumer banking products and services related to residential first mortgages, home equity lines and loans, consumer credit cards, and other consumer loans, as well as deposits. The Wealth Management segment offers credit related products, and retirement and savings solutions; and trust and investment management, asset management, and estate planning services to individuals, businesses, governmental institutions, and non-profit entities. The company also provides investment and insurance products; low-income housing tax credit corporate fund syndication services; and other specialty financing services. As of March 01, 2022, it operated through a network of 1,300 banking offices and 2,000 automated teller machines across the South, Midwest, and Texas. Regions Financial Corporation was founded in 1971 and is headquartered in Birmingham, Alabama.

Full RF Calculator →
📬

Get this BAX vs RF comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BAX vs SCHDBAX vs JEPIBAX vs OBAX vs KOBAX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.